Related Experiment Video
Updated: Nov 11, 2025

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids
Published on: April 25, 2016
Pergolide dosing compliance and factors affecting the laboratory control of equine pituitary pars intermedia
Natalie Hague1, Andrew E Durham2, Nicola J Menzies-Gow1
1Department of Clinical Sciences and Services, Royal Veterinary College, Hawkshead Lane, North Mymms, UK.
Background:
Equine pituitary pars intermedia dysfunction (PPID) is treated with daily pergolide therapy. Owner compliance and its effect on PPID control have not been previously investigated.
Methods:
Clinical records were searched to identify the sample of animals with PPID treated with pergolide from 2016 to 2019. The signalment was noted and the dose of pergolide received calculated. Animals were classified as compliant (receiving ≥90% of the veterinarian recommended dose of pergolide) or non-compliant, and as controlled (follow-up basal adrenocorticotrophic hormone concentrations within the reference range) or not.
Results:
In total, 110 animals were included. The majority (85%) were ≥16 years (mean ± SD 19.8 ± 4.4 years); the most common breeds were Cob (18%), Thoroughbred (16%) and Welsh (15%); 37% were female and 63% male. Overall, 48% were compliant and 52% non-compliant. There was no significant effect of compliance on laboratory control. Of those that were compliant, 74% were controlled, while 67% of non-compliant animals were controlled. Univariable analysis revealed a significant (p < 0.001) effect of age and breed on compliance and control, and of sex on control. On multivariable analysis, only age (compliance) and breed (compliance and control) were retained in the final model.
Conclusion:
Only half of animals received the recommended pergolide dose; however, this did not affect laboratory control of PPID.
Related Concept Videos
Dosage Regimens: Partial Pharmacokinetic Parameters
Hormones of the Pituitary Gland
The most abundantly secreted hormone from the anterior lobe is the growth hormone, which controls overall growth by...
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

